CalciMedica, Inc. Quarterly Debt-to-equity in % from Q2 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: CalciMedica, Inc. quarterly Debt-to-equity history and growth rate from Q2 2021 to Q3 2024.
CalciMedica, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 58.7 %.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	58.7	+216		Sep 30, 2024
Q2 2024	48.3	+79.8		Jun 30, 2024
Q1 2024	40.2	+57.7		Mar 31, 2024
Q4 2023	41.7	+50.6		Dec 31, 2023
Q3 2023	-158	-152	-2510%	Sep 30, 2023
Q2 2023	-31.5	-18.2	-136%	Jun 30, 2023
Q1 2023	-17.4	-105	-120%	Mar 31, 2023
Q4 2022	-8.92	-20	-180%	Dec 31, 2022
Q3 2022	-6.04	-12.7	-191%	Sep 30, 2022
Q2 2022	-13.3	-20.6	-285%	Jun 30, 2022
Q1 2022	87.3			Mar 31, 2022
Q4 2021	11.1			Dec 31, 2021
Q3 2021	6.65			Sep 30, 2021
Q2 2021	7.23			Jun 30, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.